Advancing Pancreatic Cancer Research with Experimental Models | Precision Medicine Offers Hope for Better Patient Outcomes

In this episode of SciBud, join your host Maple as we delve into the latest research illuminating the complex world of pancreatic cancer, one of the deadliest forms of the disease. With a mere 13% five-year survival rate, researchers are making strides in understanding this challenging cancer through various experimental models—from traditional two-dimensional cell cultures to innovative three-dimensional organoids and ex vivo tissue slices. We'll explore how these models inform precision medicine, tailoring treatments to individual patients' tumors, and how future technologies like AI may further enhance therapeutic strategies. While progress is being made, our discussion acknowledges the critiques of existing research and the vital importance of methodological transparency. Tune in to discover how the integration of these diverse models could lead us toward better outcomes for those battling this aggressive cancer. Stay curious and keep exploring with us on SciBud! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/130